Live Breaking News & Updates on Hyderabad based bharat biotech international

Stay informed with the latest breaking news from Hyderabad based bharat biotech international on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hyderabad based bharat biotech international and stay connected to the pulse of your community

In a nation of inequalities, India's vaccine strategy is bad economics

In a nation of inequalities, India's vaccine strategy is bad economics
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

India , Texas , United-states , New-delhi , Delhi , Bharat , Serum-institute-of-india-ltd , Astrazeneca-plc , Bharat-biotech-international-ltd , E-ltd , Texas-children-hospital-center

Covaxin 100 per cent effective against severe COVID double mutant multiple strain ICMR study

URL copied
Covaxin effective against multiple strain of coronavirus.
India's indigenously developed Bharat Biotech's coronavirus vaccine â Covaxin â works against multiple variant of Covid19. According to the Indian Council of Medical Research (ICMR) study, COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well.
Covaxin has demonstrated overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19, the city-based company said on Wednesday announcing phase 3 interim analysis results of the vaccine.
"The second interim analysis is based on accruing more than 87 symptomatic cases of COVID-19. Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 per cent (95%CI: 61-88) against mild, moderate, and severe COVID-19 disease," the vaccine maker said in a press release.

South-africa , India , United-kingdom , Brazil , Bharat , Institute-of-virology , Serum-institute , Indian-council-of-medical-research , Bharat-biotech-international-ltd , Image-source , Bharat-biotech

COVID-19 vaccine 'Covaxin' is effective against double mutant strain found in India, says ICMR

ICMR cited the findings of a study carried out by them.
Covaxin is developed locally by Hyderabad-based Bharat Biotech International Ltd. in collaboration with the ICMR -- the apex body in India for the formulation, coordination and promotion of biomedical research.
Advertisement
ICMR-National Institute of Virology has successfully isolated and cultured multiple variants of concern of SARS-CoV-2 virus: B.1.1.7 (the UK variant), B.1.1.28 (Brazil variant ) and B.1.351 (South Africa variant), said the apex health research body.
"ICMR study shows
Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well," the ICMR said in a tweet.

South-africa , India , United-kingdom , Brazil , Bharat , Institute-of-virology , Indian-council-of-medical-research , Bharat-biotech-international-ltd , Indian-council , Medical-research , Hyderabad-based-bharat-biotech-international

Covaxin effective against double mutant strain found in India: ICMR

Northlines
Covaxin effective against double mutant strain found in India: ICMR
Covid-19 vaccine Covaxin neutralizes several forms of SARS-CoV-2 and effectively neutralizes the double mutant strain, according to the Indian Council of Medical Research (ICMR).
ICMR cited the findings of a study carried out by them.

Covaxin is developed locally by Hyderabad-based Bharat Biotech International Ltd. in collaboration with the ICMR — the apex body in India for the formulation, coordination and promotion of biomedical research.

ICMR-National Institute of Virology has successfully isolated and cultured multiple variants of concern of SARS-CoV-2 virus: B.1.1.7 (the UK variant), B.1.1.28 (Brazil variant ) and B.1.351 (South Africa variant), said the apex health research body.

South-africa , India , United-kingdom , Brazil , Bharat , Institute-of-virology , Indian-council-of-medical-research , Bharat-biotech-international-ltd , Indian-council , Medical-research , Hyderabad-based-bharat-biotech-international

Covaxin effective against double mutant strain found in India: ICMR

Covaxin effective against double mutant strain found in India: ICMR
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.

South-africa , India , United-kingdom , New-delhi , Delhi , Brazil , Bharat , Institute-of-virology , Indian-council-of-medical-research , Bharat-biotech-international-ltd , Indian-council

Cadila Looks to Double Vaccine Capacity Amid Record India Surge

Apr 20 2021, 4:29 PM
April 20 2021, 2:30 AM
April 20 2021, 4:29 PM
(Bloomberg) -- Indian drugmaker Cadila Healthcare Ltd., which expects regulatory approval for its vaccine against Covid-19 by June, will potentially ramp up capacity to 240 million annual doses as the South Asian nation races to contain the worldâs fastest-growing coronavirus outbreak.
(Bloomberg) -- Indian drugmaker Cadila Healthcare Ltd., which expects regulatory approval for its vaccine against Covid-19 by June, will potentially ramp up capacity to 240 million annual doses as the South Asian nation races to contain the worldâs fastest-growing coronavirus outbreak.
Ahmedabad, Gujarat-based Cadila is expecting efficacy readings from its last stage of clinical trials in May, Sharvil Patel, the family-run firmâs managing director, said in an interview. If that data is promising, the drugmaker may double its vaccine making capabilities and is banking on a new local factory that will likely be commissioned next month, according to Patel.

Hyderabad , Andhra-pradesh , India , Ahmedabad , Gujarat , Mumbai , Maharashtra , Bharat , Abhishek-sharma , Narendra-modi , Bloomberg-indian , Cadila-zyco

Cadila Looks to Double Vaccine Capacity Amid Record India Surge

Cadila Looks to Double Vaccine Capacity Amid Record India Surge
bloombergquint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloombergquint.com Daily Mail and Mail on Sunday newspapers.

India , Ahmedabad , Gujarat , Mumbai , Maharashtra , Bharat , Abhishek-sharma , Bloomberg-indian , Cadila-zyco , Sharvil-patel , Cadila-healthcare-ltd , Astrazeneca-plc

India Fast-Tracks Approval for Foreign Vaccines Amid Second Wave

India Fast-Tracks Approval for Foreign Vaccines Amid Second Wave
Bloomberg
1 hr ago
Muneeza Naqvi
© Photographer: INDRANIL MUKHERJEE/AFP
A staff walks into a vaccination area, at the Saifee Hospital in Mumbai.
(Bloomberg) -- India will fast-track approvals for Covid-19 vaccines approved by governments overseas in order to have a wider pool of shots as it struggles to control its soaring second wave of infections, effectively opening the door to shots made by Pfizer Inc. and Moderna Inc.
A government panel has recommended that inoculations approved by drug regulators in the U.S., U.K., European Union, Japan or which are listed in the World Health Organization, may be granted emergency use approval in the South Asian nation, according to a statement from the Indian health ministry.

Brazil , Japan , Mumbai , Maharashtra , India , Bharat , Pfizer-inc , European-union , Serum-institute-of-india-ltd , Moderna-inc , World-health-organization

India fast-tracks approval for foreign vaccines amid second wave

India fast-tracks approval for foreign vaccines amid second wave
thepeninsulaqatar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepeninsulaqatar.com Daily Mail and Mail on Sunday newspapers.

Brazil , Japan , Mumbai , Maharashtra , India , Bharat , Serum-institute-of-india-ltd , World-health-organization , Astrazeneca-plc , Bharat-biotech-international-ltd , Health-ministry

Russia's Sputnik V vaccine gets approval for emergency use in India

Russia's Sputnik V vaccine gets approval for emergency use in India
gulfnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gulfnews.com Daily Mail and Mail on Sunday newspapers.

Mumbai , Maharashtra , India , Hyderabad , Andhra-pradesh , Russia , New-delhi , Delhi , Brazil , Russian , Bharat , Narendra-modi